Macrocyclic compounds as hepatitis c virus inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 498/08 (2006.01) A61K 31/407 (2006.01) A61K 31/439 (2006.01) A61K 31/4748 (2006.01) A61P 31/14 (2006.01) C07D 487/08 (2006.01)

Patent

CA 2761650

The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

La présente invention concerne des composés de formule I ou leurs sels, esters ou promédicaments pharmaceutiquement acceptables, qui inhibent l'activité sérine protéasique, particulièrement l'activité de la protéase NS3-NS4A du virus de l'hépatite C (VHC). Par conséquent, les composés de la présente invention interfèrent avec le cycle de vie du virus de l'hépatite C et sont également utiles comme agents antiviraux. La présente invention concerne également des compositions pharmaceutiques comprenant les composés susmentionnés pour administration à un patient souffrant d'une infection par VHC. L'invention concerne également des procédés de traitement d'une infection par VHC chez un patient par administration d'une composition pharmaceutique comprenant les composés de la présente invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Macrocyclic compounds as hepatitis c virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic compounds as hepatitis c virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic compounds as hepatitis c virus inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1428924

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.